From Dr. Seymour's end of year statement in 2007:
We believe that we should have sufficient data in hand for our broad-spectrum nanoviricide
to be able to file a pre-IND application with the FDA within the next 12-15 months. The pre-IND
application will enable us to meet with the FDA staff and obtain guidance for further studies
needed for filing an IND (Investigational New Drug) application. We expect that within 1 to 2
years from IND approval, we should be able to file a New Drug Application (NDA) to obtain
approval for our first drug.
It doesn't matter what I present, as they are all caveated "based on assumptions" and "no guarantee" they can always claim they haven't really missed the deadlines, it wasn't in their control to meet them.
You ask for specific deadlines that this company has stated and missed. I give them, and you explain why these are not legitimate because we were discussing the mouse studies and not the company missing deadlines. You ask for them from this board, and I provide it.
Let's make it easier. Can you give an example of a deadline that this company HAS met?
FYI, I am NOT a short, I am an investor, have never sold a single share, and will not until July 1, 2011 if there is no movement on the pre-INDA meeting with the FDA.
Note to TheDane: Please feel free to attack my arguments, but don't make assumptions about my position. (i am limited to 3 posts here, so this note is in response to a completely inaccurate post regarding my position). If you need to attack the messenger instead of the message, that is a very telling sign.
